Vijaypd Ceutical IPO is a fixed price issue of INR 19.25 crores. The issue is entirely a fresh issue of 0.55 crore shares. The price for Vijaypd's share is INR 35 each and the lot size for an application is 4,000. The minimum amount of investment required by an individual investor is INR 2,80,000 (8,000 shares). The IPO subscription will open on Sep 29, 2025 and close on Oct 1, 2025. IPO will list on NSE SME with a tentative listing date fixed as Oct 7, 2025.
Company Background
Vijaypd Ceutical Ltd. was founded in 1971 as a Private Limited Company and converted into a Public Limited Company in 2024. Its head office is located in Mumbai, Maharashtra. The company is a distributor and supplier of pharmaceutical and consumer goods, serving over 2,100 pharmacies, clinics and nursing homes across West India. It partners with more than 170 healthcare manufacturers and manages over 19,000 SKUs. Vijaypd holds certifications from the FDA, FSSAI and BMS, reflecting strong compliance, client management and experienced promoters.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price
and the grey market price. It is the premium amount paid for the traded
IPO shares. It plays an important role in IPOs as it reflects how the
IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being
listed officially on the stock exchange.
Vijaypd Ceutical IPO
GMP Date
IPO Price
GMP
Last Updated
-
-
-
-
**The GMP prices displayed here are solely for informational
purposes related to the grey market news. India IPO does not engage
in or facilitate grey market trading, nor are these rates (sub2)
indicative of any trading activity. We also do not recommend or
endorse participation in the grey market.**
Vijaypd Ceutical IPO Details
Detail
Description
IPO Date
September 29, 2025 to October 1, 2025
Listing Date
[.]
Face Value
₹10 per share
Issue Price Band
₹35 per share
Lot Size
4,000 Shares
Sale Type
Fresh Capital
Total Issue Size
55,00,000 shares (aggregating up to ₹19.25 Cr)
Reserved for Market Maker
2,84,000 shares (aggregating up to ₹0.9940 Cr) Shreni Shares Ltd.
Net Offered to Public
52,16,000 shares (aggregating up to ₹18.26 Cr)
Issue Type
Fixed Price IPO
Listing At
NSE SME
Share Holding Pre Issue
1,40,28,686 shares
Share Holding Post Issue
1,95,28,686 shares
Vijaypd Ceutical IPO Timeline
Detail
Description
IPO Open Date
Mon, Sep 29, 2025
IPO Close Date
Wed, Oct 1, 2025
Tentative Allotment
Fri, Oct 3, 2025
Initiation of Refunds
Mon, Oct 6, 2025
Credit of Shares to Demat
Mon, Oct 6, 2025
Tentative Listing Date
Tue, Oct 7, 2025
Cut-off time for UPI mandate confirmation
5 PM on Wed, Oct 1, 2025
Vijaypd Ceutical IPO Lot Size
Application
Lots
Shares
Amount
Individual investors (Retail) (Min)
2
8,000
₹2,80,000
Individual investors (Retail) (Max)
2
8,000
₹2,80,000
HNI (Min)
3
12,000
₹4,20,000
Vijaypd Ceutical IPO Promoter Holding
Share Holding Pre Issue
Share Holding Post Issue
Promoter Holding Pre Issue
78.30%
Promoter Holding Post Issue
56.25%
Competitive Strength:
⦁ A diverse product portfolio that offers a broad range of products and covers a wider range of consumers.
⦁ Long-term relationship management with clients that contributes to stable revenue and connections.
Vijaypd Ceutical IPO Financial Information
Period Ended
Assets
Revenue
Profit After Tax
Net Worth
Total Borrowing
31 Mar 2025
57.15
107.59
4.80
32.17
21.77
31 Mar 2024
33.27
54.34
1.65
1.00
30.04
31 Mar 2023
32.87
50.59
0.18
4.93
25.56
Amount in ₹
Crore
Key Performance Indicator
KPI
Values
ROE
28.91%
ROCE
17.30%
Debt/Equity
0.68
RoNW
14.91%
PAT Margin
4.49%
EBITDA Margin
8.04%
Pre IPO
Post IPO
EPS (Rs)
P/E (x)
Conclusion
Vijaypd Ceutical IPO offers an opportunity to invest in a 50+ year old company with a stable presence, strong client connections and consumer trust. The promoters aim to diversify beyond the distribution model, expand into new cities and strengthen market position. With significant recent financial growth, industry experience and a robust network, the IPO proceeds will be utilized for API manufacturing, capital expenditure and general corporate purposes.